Cargando…

Off label therapies for testosterone replacement

The incidence of hypogonadism has been steadily increasing over the last few years. Exogenous testosterone has been the standard treatment for hypogonadal men, but is associated with suppression of spermatogenesis as well as other possible adverse effects. There are other medications, currently cons...

Descripción completa

Detalles Bibliográficos
Autores principales: DiGiorgio, Lorenzo, Sadeghi-Nejad, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182219/
https://www.ncbi.nlm.nih.gov/pubmed/28078215
http://dx.doi.org/10.21037/tau.2016.08.15
_version_ 1782485826307883008
author DiGiorgio, Lorenzo
Sadeghi-Nejad, Hossein
author_facet DiGiorgio, Lorenzo
Sadeghi-Nejad, Hossein
author_sort DiGiorgio, Lorenzo
collection PubMed
description The incidence of hypogonadism has been steadily increasing over the last few years. Exogenous testosterone has been the standard treatment for hypogonadal men, but is associated with suppression of spermatogenesis as well as other possible adverse effects. There are other medications, currently considered “off label” for androgen replenishment, that exert their effect through modulation of the hypothalamic-gonadal axis. These medications increase endogenous testosterone levels and offer a different therapeutic approach. This review will focus on these alternative (off-label) therapies for androgen replacement in men.
format Online
Article
Text
id pubmed-5182219
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-51822192017-01-11 Off label therapies for testosterone replacement DiGiorgio, Lorenzo Sadeghi-Nejad, Hossein Transl Androl Urol Review Article The incidence of hypogonadism has been steadily increasing over the last few years. Exogenous testosterone has been the standard treatment for hypogonadal men, but is associated with suppression of spermatogenesis as well as other possible adverse effects. There are other medications, currently considered “off label” for androgen replenishment, that exert their effect through modulation of the hypothalamic-gonadal axis. These medications increase endogenous testosterone levels and offer a different therapeutic approach. This review will focus on these alternative (off-label) therapies for androgen replacement in men. AME Publishing Company 2016-12 /pmc/articles/PMC5182219/ /pubmed/28078215 http://dx.doi.org/10.21037/tau.2016.08.15 Text en 2016 Translational Andrology and Urology. All rights reserved.
spellingShingle Review Article
DiGiorgio, Lorenzo
Sadeghi-Nejad, Hossein
Off label therapies for testosterone replacement
title Off label therapies for testosterone replacement
title_full Off label therapies for testosterone replacement
title_fullStr Off label therapies for testosterone replacement
title_full_unstemmed Off label therapies for testosterone replacement
title_short Off label therapies for testosterone replacement
title_sort off label therapies for testosterone replacement
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182219/
https://www.ncbi.nlm.nih.gov/pubmed/28078215
http://dx.doi.org/10.21037/tau.2016.08.15
work_keys_str_mv AT digiorgiolorenzo offlabeltherapiesfortestosteronereplacement
AT sadeghinejadhossein offlabeltherapiesfortestosteronereplacement